 |
||
 |
||
 |
||
 |
||
 |
|
Heading for New
Treatments |
|
|
|
|
||
|
|
|
|
Scientific Advisory Board | |
|
|
|
|
|
|
|
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
 |
||
Expansion of MPD Research Alliance
The MPD Foundation announces that in June, 2008 it will publish a call for proposals to participate in the MPD Research Alliance, a collaborative multi-investigator, multi-year project focused on advancing the understanding of the MPDs and contributing to the rapid discovery and development of effective treatments.
The specific goal of the MPD Research Alliance is to identify, within the shortest time frame possible, candidates for targeted drugs for the Philadelphia chromosome negative myeloproliferative disorders for all MPD patients. Currently this project involves investigators at Harvard, Mt. Sinai, and the Mayo Clinic. It is the intention of the MPD Foundation to broaden participation in this project as funding allows to encourage accelerated discovery of effective treatments for the MPDs.
Awards will start at $100,000 per year and may be larger based on the quality and potential impact of a proposal; awards are renewable for additional years based on peer review by the Scientific Advisory Board of the MPD Foundation and on available funding.
